IL6 and neoplasm: Furthermore, the inflammation-related interactions (Interleukin 6/Janus kinase/Signal Transducer and Activator of Transcription protein) signaling pathway is hyperactivated, turns out to perturbing anti-tumor immune responses to encourage tumor progression (Figure 4) [192].